National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 33912 [05-11559]
Download as PDF
33912
Federal Register / Vol. 70, No. 111 / Friday, June 10, 2005 / Notices
Dated: June 6, 2005.
LaVerne Y. Stringfield,
Direcotr, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11572 Filed 6–9–05:8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group, Microbiology and Infectious Diseases
Research Committee, Microbiology &
Infectious Diseases Research Committee
(MIDRC) June 2005.
Date: June 23–24, 2005.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Washington, 1221 22nd
Street, NW., Washington, DC 20037.
Contact Person: Annie Walker-Abbey, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, RM. 3266,
Bethesda, MD 20892–7616, (301) 451–2671,
aabbey@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS.)
Dated: June 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11559 Filed 6–9–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003
17:22 Jun 09, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Predictive ADME–Tox.
Date: June 30–July 1, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contract Person: Laur K. Moen, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–12,
Bethesda, MD 20892, 301–594–3998,
moenl@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS).
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Postdoctoral Research Training in the
Biomedical Sciences.
Date: June 29, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Brian R. Pike, PhD., Office
of Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, 301–594–3907,
pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and Development
Biology Research; 93.88, Minority Access to
Research Careers; 93.96, Special Minority
Initiatives, National Institutes of Health,
HHS)
Dated: June 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11561 Filed 6–9–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11560 Filed 6–9–05; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set in forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
E:\FR\FM\10JNN1.SGM
10JNN1
Agencies
[Federal Register Volume 70, Number 111 (Friday, June 10, 2005)]
[Notices]
[Page 33912]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group, Microbiology and Infectious Diseases Research
Committee, Microbiology & Infectious Diseases Research Committee
(MIDRC) June 2005.
Date: June 23-24, 2005.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Washington, 1221 22nd Street, NW., Washington,
DC 20037.
Contact Person: Annie Walker-Abbey, PhD, Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, RM. 3266, Bethesda, MD 20892-7616, (301) 451-2671,
aabbey@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS.)
Dated: June 1, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-11559 Filed 6-9-05; 8:45 am]
BILLING CODE 4140-01-M